Grifols, a global healthcare leader and prominent manufacturer of plasma-derived medicines, has achieved the distinction of being ranked the number one biotechnology company in the S&P Dow Jones Sustainability Indices (DJSI). This marks the company’s fifth consecutive year in the prestigious indices, a testament to its steadfast dedication to sustainability and environmental, social, and governance (ESG) practices.
This recognition coincides with Grifols achieving its highest-ever S&P Global Corporate Sustainability Assessment (CSA) score of 70 points, reflecting a remarkable seven-point increase from the previous year. The milestone underscores the company’s progress and commitment to sustainable growth, ethical business practices, and creating long-term value for stakeholders.
A Commitment to Sustainability Excellence
Grifols’ ascent to the top position in the DJSI demonstrates its sustained focus on advancing ESG initiatives. Over the years, the company has consistently enhanced its practices, striving to address pressing global challenges while fostering resilience and innovation within its operations.
The Dow Jones Sustainability Index evaluates global sustainability leaders through S&P Global’s CSA, an annual benchmarking assessment. This year, more than 13,000 companies from 62 industries were invited to participate, with the index highlighting the top 10% of the largest 2,500 companies in the S&P Global Broad Market Index.
“It is an honor for Grifols to once again be recognized in the Dow Jones Sustainability Index as one of the world’s most sustainable companies,” said Nacho Abia, Grifols CEO. “As we continue to deliver consistently strong financial and operational performance, we remain committed to achieving best-in-class ESG practices and advancing our ambitious 2030 sustainability goals.”
Key Areas of ESG Recognition
Grifols’ recent ranking and CSA score improvement reflect its impactful initiatives across key ESG dimensions. S&P Global commended the company for its efforts in several critical areas:
1. Environmental Leadership
- Climate Strategy: Grifols continues to advance its transition toward a low-carbon economy, working to reduce greenhouse gas emissions and enhance energy efficiency across its global operations.
- Sustainable Supply Chain: The company has strengthened its commitment to fostering responsible sourcing practices, promoting transparency, and ensuring sustainability throughout its supply chain.
- Sustainability Reporting: Grifols earned the highest possible score in sustainability reporting, showcasing its commitment to providing comprehensive and transparent insights into its environmental performance and goals.
2. Social Responsibility
- Employee Well-Being: The company prioritizes maintaining a safe and healthy workplace for its workforce, ensuring that employees are supported and valued at every level.
- Human Rights: Grifols has made significant strides in embedding human rights principles throughout its operations, ensuring fair labor practices and equitable treatment across its global footprint.
- Ethical Marketing: For yet another year, S&P Global awarded Grifols the highest score for its dedication to ethical marketing practices, which align with its mission to serve patients responsibly and transparently.
3. Governance and Risk Management
- Ethical Business Practices: Grifols received top scores for its governance framework and risk management processes, demonstrating its ability to navigate challenges while upholding strong ethical standards.
- Strategic Oversight: The company’s leadership is deeply engaged in advancing its sustainability agenda, with a clear focus on integrating ESG principles into its broader business strategy.
Driving Toward 2030 Sustainability Goals
Grifols remains focused on achieving its 2030 sustainability objectives, which include ambitious targets for environmental impact reduction, social equity, and corporate governance. The company’s long-term strategy emphasizes innovation, collaboration, and accountability, aligning its operations with global efforts to build a more sustainable and equitable future.
Key goals in the company’s roadmap include:
- Significantly reducing carbon emissions to support the global fight against climate change.
- Increasing the use of renewable energy and sustainable materials across manufacturing processes.
- Continuing to expand initiatives that promote diversity, inclusion, and employee well-being.
- Strengthening community outreach and patient-centric programs to create lasting social impact.
